Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Endocrine Disorders
Published in: BMC Endocrine Disorders 1/2016

Open Access 01-12-2016 | Research article

Pro inflammatory interleukins and thyroid function in Naswar (dipping tobacco) users: a case control study

Authors: Faiza Sajid, Samina Bano

Published in: BMC Endocrine Disorders | Issue 1/2016

Login to get access

Abstract

Background

Naswar is a type of finely ground, moistened smokeless dipping tobacco product being commonly used in Pakistan. Although, nicotine is the most important psychoactive agent present in Naswar, it also exerts immunosuppressive effects and could alter the levels of cytokines. Additionally, the effects of Naswar consumption on thyroid hormones are not known.

Methods

Eighty healthy males aged 16–43 years were selected for the study and were divided into a control group comprising 31 healthy subjects with no history of tobacco use in any form, with age matched test group comprising 49 exclusive Naswar users who were consuming Naswar for at least 1 year. Estimation of serum interleukin (IL)-1β, IL-6, free thyroxine (FT4), free triiodothyronine (FT3) and thyroid stimulating hormone (TSH) was carried out. The data was analyzed by statistical programme (SPSS) using student's independent samples t-test. One way Anova followed by post hoc Tukey test was applied to assess parameters in Naswar users grouped according to duration of Naswar usage. Pearson’s correlation coefficient was applied to assess correlations between parameters.

Results

IL-1β was found to be significantly lowered in Naswar users compared to the control group whereas serum FT3 and FT4 levels in Naswar users were significantly raised compared to the control group. However, no differences in the levels of serum IL-6 and TSH between Naswar users and the control group were found. Also, serum FT3 and FT4 were consistently raised whereas IL-1β was lowered in Naswar users irrespective of duration of Naswar consumption. IL-1β was negatively correlated with FT3 in Naswar users.

Conclusion

The findings suggest that Naswar users might be in an immune suppressive state as evident by the lowered levels of interleukin 1β. Additionally, alterations in the levels of thyroid hormones signify the impact of Naswar consumption on thyroid function.
Literature
1.
Bhonsle RB, Murti PR, Gupta PC. Tobacco habits in India. In: Gupta PC, Hamner J III, Murti P (eds). Control of tobacco-related cancers and other diseases. Proceedings of an International Symposium, 15.19 January 1990; Mumbai: TIFR, Oxford University Press; 1992:25.46.
2.
Zakiullah, Saeed M, Muhammad N, Khan SA, Gul F, Khuda F, Humayun M, Khan H. Assessment of potential toxicity of a smokeless tobacco product (Naswar) available on the Pakistani market. Tob. Control. 2011;21:396–401.
3.
Saleem S, Azhar A, Hameed A, Khan MA, Abbasi ZA, Qureshi NR, Ajmal M. P53 (Pro72Arg) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, Naswar and manipuri addicted patients of Pakistan. Oral Oncol. 2013;49:818–23.CrossRefPubMed
4.
5.
Tanaka T, Kishimoto T. The biology and medical implications of interleukin-6. Cancer Immunol Res. 2014;2(4):288–94.CrossRefPubMed
6.
Marth E, Jelovcan S, Kleinhappl B, Gutschi A, Barth S. The effect of heavy metals on the immune system at low concentrations. Int J Occup Med Environ Health. 2001;14(4):375–86.PubMed
7.
Kanakdande V, Patil KP, Nayyar AS. Comparative evaluation of clinical, hematological and systemic inflammatory markers in smokers and non-smokers with chronic periodontitis. Contemp Clin Dent. 2015;6(3):348–57.CrossRefPubMedPubMedCentral
8.
Tappia PS, Troughton KL, Langley-Evans SC, Grimble RF. Cigarette smoking influences cytokine production and antioxidant defenses. Clin Sci. 1995;88:485–9.CrossRefPubMed
9.
Sopori ML, Kozak W. Immunomodulatory effects of cigarette smoke. J Neuroimmunol. 1998;83(1-2):148–56.CrossRefPubMed
10.
Yoshikawa H, Kurokawa M, Ozaki N, Nara K, Atou K, Takada E, Kamochi H, Suzuki N. Nicotine inhibits the production of proinflammatory mediators in human monocytes by suppression of I-kB phosphorylation and nuclear factor-kB transcriptional activity through nicotinic acetylcholine receptor α7. Clin Exp Immunol. 2006;146:116–23.CrossRefPubMedPubMedCentral
11.
Shiels MS, Katki HA, Freedman ND, Purdue MP, Wentzensen N, Trabert B, et al. Cigarette smoking and variations in systemic immune and inflammation markers. J Natl Cancer Inst. 2014;106(11):3989–95.
12.
Frost-Pineda K, Liang Q, Liu J, Rimmer L, Jin Y, Feng S, Kapur S, Mendes P, Roethig H, Sarkar M. Biomarkers of potential harm among adult smokers and nonsmokers in the total exposure study. Nicotine Tob Res. 2011;13(3):182–93.CrossRefPubMed
13.
Liu J, Liang Q, Frost-Pineda K, Muhammad-Kah R, Rimmer L, Roethig H, Mendes P, Sarkar M. Relationship between biomarkers of cigarette smoke exposure and biomarkers of inflammation, oxidative stress, and platelet activation in adult cigarette smokers. Cancer Epidemiol Biomarkers Prev. 2011;20(8):1760–69.CrossRefPubMed
14.
Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1, IL-2, IFN-g, and TNF-α production by cigarette smoke extracts. J Allergy Clin Immunol. 2000;106:280–7.CrossRefPubMed
15.
Kim TH, Kim SJ, Lee SM. Stimulation of the alpha7 nicotinic acetylcholine receptor protects against sepsis by inhibiting toll like receptor via phosphoinositide 3-kinase activation. J Infect Dis. 2014;209(10):1668–77.CrossRefPubMed
16.
Cui WY, Li MD. Nicotinic modulation of innate immune pathways via alpha7 nicotinic acetylcholine receptor. J Neuroimmune Pharmacol. 2010;5(4):479–88.CrossRefPubMed
17.
Effraimidis G, Tijssen JG, Wiersinga WM. Discontinuation of smoking increases the risk for developing thyroid peroxidase antibodies and/or thyroglobulin antibodies: a prospective study. J Clin Endocrinol Metab. 2009;94:1324–8.CrossRefPubMed
18.
Belin RM, Astor BC, Powe NR, Ladenson PW. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2004;89:6077–86.CrossRefPubMed
19.
20.
Soldin OP, Goughenour BE, Gilbert SZ, Landy HJ, Soldin SJ. Thyroid hormone levels associated with active and passive cigarette smoking. Thyroid. 2009;19:817–23.CrossRefPubMedPubMedCentral
21.
Czarnywojtek A, Warmuz-Stangierska I, Zdanowska J, Florek E, Zgorzlewicz M, Ruchata M, Stangierski A, Sowiński J. Smoking and thyroid disease--review of literature. Przegl Lek. 2009;66:878–81.PubMed
22.
23.
Czarnywojtek A, Kurdybacha P, Florek E, Warmuz-Stangierska I, Zdanowska J, Zgorzlewicz M, Ruchata M, Sowiński J. Smoking and thyroid diseases--what is new? Przegl Lek. 2010;67(10):1056–60.PubMed
24.
Wiersinga WM. Nonthyroidal illness. In: Braverman LE, Utiger RD, editors. The thyroid. Philadelphia: Lippincott; 2005. p. 246–63.
25.
Cloëz-Tayarani I, Changeux JP. Nicotine and serotonin in immune regulation and inflammatory processes: a perspective. J Leukoc Biol. 2007;81(3):599–606.CrossRefPubMed
26.
Song D-K, Im Y-B, Jung J-S, Suh H-W, Huh S-O, Song J-H, Kim Y-H. Central injection of nicotine increases hepatic and splenic interleukin 6 (IL-6) mRNA expression and plasma IL-6 levels in mice: involvement of the peripheral sympathetic nervous system. FASEB J. 1999;13(10):1259–67.PubMed
27.
Brown GP, Iwamoto GK, Monick MM, Hunninghake GW. Cigarette smoking decreases interleukin 1 release by human alveolar macrophages. Am J Physiol. 1989;256:C260–4.PubMed
28.
Seyedroudbari SA, Khan MM. In vitro effects of smokeless tobacco extract on tumor necrosis factor-alpha (TNF-alpha) and interleukin-1beta (IL-1beta) production, and on lymphocyte proliferation. Toxicon. 1998;36(4):631–7.CrossRefPubMed
29.
Francus T, Romano PM, Manzo G, Fonacier L, Arango N, Szabo P. IL-1, IL-6, and PDGF mRNA expression in alveolar cells following stimulation with a tobacco-derived antigen. Cell Immunol. 1992;145:156–74.CrossRefPubMed
30.
31.
Palmer RM, Wilson RF, Hasan AS, Scott DA. Mechanisms of action of environmental factors--tobacco smoking. J Clin Periodontol. 2005;32:180–95.CrossRefPubMed
32.
Tymkiw KD, Thunell DH, Johnson GK, Joly S, Burnell KK, Cavanaugh JE, Guthmiller JM. Influence of smoking on gingival crevicular fluid cytokines in severe chronic periodontitis. J Clin Periodontol. 2011;38(3):219–28.CrossRefPubMed
33.
Asvold BO, Bjøro T, Nilsen T, Vatten LJ. Tobacco smoking and thyroid function: a population-based study. Arch Intern Med. 2007;167:1428–32.CrossRefPubMed
34.
Jorde R, Sundsfjord J. Serum TSH levels in smokers and non-smokers. The 5 Th Tromsø study. Exp Clin Endocrinol Diabetes. 2006;114:343–7.CrossRefPubMed
35.
Knudsen N, Bülow I, Laurberg P, Ovesen L, Perrild H, Jørgensen T. Parity is associated with increased thyroid volume solely among smokers in an area with moderate to mild iodine deficiency. Eur J Endocrinol. 2002;146:39–43.CrossRefPubMed
36.
Balhara YS, Deb KS. Impact of tobacco on thyroid function. Thyroid Res Pract. 2014;11:6–16.CrossRef
37.
Sepkovic DW, Haley NJ, Wynder EL. Thyroid activity in cigarette smokers. Arch Intern Med. 1984;144:501–3.CrossRefPubMed
38.
Karakaya A, Tunçel N, Alptuna G, Koçer Z, Erbay G. Influence of cigarette smoking on thyroid hormone levels. Hum Toxicol. 1987;6:507–9.CrossRefPubMed
39.
Christensen SB, Ericsson UB, Janzon L, Tibblin S, Melander A. Influence of cigarette smoking on goiter formation, thyroglobulin, and thyroid hormone levels in women. J Clin Endocrinol Metab. 1984;58(4):615–8.CrossRefPubMed
40.
Weetman AP. Autoimmune thyroid disease: propagation and progression. Eur J Endocrinol. 2003;148(1):1–9.CrossRefPubMed
41.
Wajner SM, Maia AL. New insights toward the acute non-thyroidal illness syndrome. Front Endocrinol. 2012;3:8.CrossRef
42.
Yamashita S, Kimura H, Ashizawa K, Nagayama Y, Hirayu H, Izumi M, Nagataki S. Interleukin-1 inhibits thyrotrophin-induced human thyroglobulin gene expression. J Endocrinol. 1989;122(1):177–83.CrossRefPubMed
43.
Ashizawa K, Yamashita S, Tobinaga T, Nagayama Y, Kimura H, Hirayu H, Izumi M, Nagataki S. Inhibition of human thyroid peroxidase gene expression by interleukin 1. Acta Endocrinol (Copenh). 1989;121(4):465–9.
44.
Sato K, Satoh T, Shizume K, Ozawa M, Han DC, Imamura H, Tsushima T, Demura H, Kanaji Y, Ito Y. Inhibition of 125I organification and thyroid hormone release by interleukin-1, tumor necrosis factor-alpha, and interferon-gamma in human thyrocytes in suspension culture. J Clin Endocrinol Metab. 1990;70:1735–43.CrossRefPubMed
45.
Enomoto T, Sugawa H, Kosugi S, Inoue D, Mori T, Imura H. Prolonged effects of recombinant human interleukin-1 alpha on mouse thyroid Function. Endocrinology. 1990;127:2322–27.CrossRefPubMed
46.
Kammoun-Krichen M, Bougacha-Elleuch N, Mnif M, Bougacha F, Charffedine I, Rebuffat S, Rebai A, Glasson E, Abid M, Ayadi F, Péraldi-Roux S, Ayadi H. IL-1β a potential factor for discriminating between thyroid carcinoma and atrophic thyroiditis. Eur Cytokine Netw. 2012;23(3):101–6.PubMed
Metadata
Title
Pro inflammatory interleukins and thyroid function in Naswar (dipping tobacco) users: a case control study
Authors
Faiza Sajid
Samina Bano
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2016
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-016-0127-5

Other articles of this Issue 1/2016

BMC Endocrine Disorders 1/2016 Go to the issue

Research article

Diabetes related knowledge, self-care behaviours and adherence to medications among diabetic patients in Southwest Ethiopia: a cross-sectional survey

Research article

Abnormal phosphorylation of Tie2/Akt/eNOS signaling pathway and decreased number or function of circulating endothelial progenitor cells in prehypertensive premenopausal women with diabetes mellitus

Research article

Sulfonylurea use and the risk of hospital readmission in patients with type 2 diabetes

Case report

Severe hyperkalemia following adrenalectomy for aldosteronoma: prediction, pathogenesis and approach to clinical management- a case series

Research article

Retinal blood flow is increased in type 1 diabetes mellitus patients with advanced stages of retinopathy

Research article

Cost effectiveness and value of information analyses of islet cell transplantation in the management of ‘unstable’ type 1 diabetes mellitus
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits